Navigation Links
Amsterdam Molecular Therapeutics Reports Full Year Results 2008
Date:2/24/2009

s in line with the guidance AMT has given for 2008.

"Despite the setback in the filing date for AMT's lead product GlyberaTM, our Company made substantial progress in 2008 with positive clinical data for GlyberaTM, the development of three new products and the strengthening of our production platform as well as our organization. Because of these important developments we are confident in AMT's future success," said Sander van Deventer, CEO of AMT.

Conference call and webcast presentation

AMT will conduct a conference call open to the public today at 3.00 p.m. CET, which will also be webcast. The dial-in number for the Netherlands is 0800-949-4166 (toll free). The number for Germany is 0800-000-22-63 (toll free). For the UK the number is +44(0)207-107-0611 and for the rest of Europe: +41-91-610-5600. The number for the USA is +1-866-291-4166 (toll free). The webcast can be accessed via AMT's website at http://www.amtbiopharma.com. Please go to the website 15 minutes prior to the call to register, download and install the necessary audio software. Playback of the call will be availably for 24 hours after the call. Dial In: +41-91-612-4330; +44(0)20-7108-6233; or +1-866-416-2558. The archived webcast also will be available for replay shortly after the close of the call.

About Amsterdam Molecular Therapeutics

AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV production platform. As such, AMT's proprietary platform holds tremendous promise for thousands of rare (orphan) diseases, especially the
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Amsterdam Molecular Therapeutics Reports Half Year Results 2008
2. Amsterdam Molecular Therapeutics Part of Next Biotech Index
3. Amsterdam Molecular Therapeutics to Appoint George Morstyn to Supervisory Board
4. Amsterdam Molecular Therapeutics to Appoint Alexander Ribbink to Supervisory Board
5. Amsterdam Molecular Therapeutics Reports Full Year Results 2007
6. Amsterdam Molecular Therapeutics to Appoint Philippe van Holle (Celgene) to Supervisory Board
7. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
8. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
9. Data on WaferGens SmartChip Real-Time PCR System(TM) to be Presented at 16th International Molecular Medicine Tri-Conference
10. Frost & Sullivan Names Naviscan a Leader in the Future of Molecular Breast Imaging
11. Fraunhofer USA Center for Molecular Biotechnology Receives Gates Foundation Grant for Avian Influenza Vaccine Development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... ,, MOUNTAINVIEW,Calif.,Nov.23/PRNewswire/--...oredhealthcarecompaniesfordemonstratingleadershipa...einHealthcareInnovationAwardsBanquetheldinSanAnton...bin/prnh/20081117/FSLOGO ) ,, TheHealthcareInno...icantcontributiontothedeliveryandmanagementofhealt...
(Date:11/20/2009)... , , , , , , , , , ... , , AUDIO: , A team of scie...e University of Arizona, Cold Spring Harbor Labora...cing the DNA of corn. The... , , ... , , , , , , , ...
(Date:11/20/2009)... , , SEATTLE, Nov. 20 /PRNewswire-FirstCa... announced that the U.S. Food and Drug Administrat...e Company,s amended Biologics License Application ...ete response. The FDA has assigned a Prescription... which time it will respond to Dendreon,s amended ...
(Date:11/20/2009)... , , SEATTLE, Nov. 20 /PRNewswire-Firs...d MTA: CTIC) announced today that the Ninth Circui...order and ruled that CTI should be allowed to purs...ng the case back to the District Court for trial. ...,s former third-party reimbursement consultant for...
Breaking Biology Technology:Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2
... For a woman facing,gynecologic cancer surgery, he...e a gynecologic oncologist, a physician who has un...nt of cancers of the female reproductive,system. T...proximity to,other major organs in the abdomen oft...roductive organs can easily spread to the bladder,...
...search firm expands its presence in Europe ... BOSTON, April 7, 2008 The company is pleased to,...ctor based in the United,Kingdom. Penny will work ...te the continuing expansion of the company,s Europ...provision of actionable insight to,research manage...
... MaxCyte, Inc., a,clinical-stage therapeutics com...loading systems, announces that Anthony Recupero, ...te, will present on Tuesday,April 8, 2008, at 2:00...rid, Spain. Dr. Recupero,s presentation will discu...ies in the context of clinical experiences in,card...
Other Biology Technology:Gynecologic Oncologist, With Board Certification in GYN Oncology, OB/GYN, and Surgery Offers Women With Cancer the Newest Treatment Frontier: the Surgical Robot 2Observant LLC Appoints Two New Directors to the Senior Management Team 2
(Date:11/23/2009)... release is available in German . , Not jus...g journey every year. Researchers at Princeton Uni...e for Ornithology in Radolfzell, Germany studied t...y of bats, the so-called "Vespertilionidae" with t...at the migration over short as well as long distan...
(Date:11/22/2009)...monly inherited gene deletion can increase the lik...row transplantation, an international team of rese...issue of Nature Genetics . When the gene, called ...esent in the recipient,s, transplants have a signi...wn as graft-versus-host disease, in which immune c...
(Date:11/20/2009)...T researchers are at work on many scientific and t...ation has recently provided support that totals ne...ollowing investigators under the American Recovery...ers have been awarded grants for investigation of ...ofessor of physics, will enhance the capabilities ...
Breaking Biology News(10 mins):We're off then: The evolution of bat migration 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Scottsdale Facility to Be First in U S to Showcase True REST Technology 4597 1Scottsdale Facility to Be First in U S to Showcase True REST Technology 4597 2Scottsdale Facility to Be First in U S to Showcase True REST Technology 4597 3Have a Purpose in Life 3F You Might Live Longer 49005 1Have a Purpose in Life 3F You Might Live Longer 49005 2Have a Purpose in Life 3F You Might Live Longer 49005 3Nuvo Research and Covidien sign U S license and development agreement for Pennsaid 28R 29 and Pennsaid Plus 28R 29 49003 1Nuvo Research and Covidien sign U S license and development agreement for Pennsaid 28R 29 and Pennsaid Plus 28R 29 49003 2Nuvo Research and Covidien sign U S license and development agreement for Pennsaid 28R 29 and Pennsaid Plus 28R 29 49003 3
... Have a great idea or invention but don,t know wh...r an upcoming day of four workshops for first-time...velopment Center and the Alumni Association of NJI...er from 9:30 a.m. 3 p.m., the event will feature ... help launch that dream. , "I Have an Idea, Now...
... Recognizing that energy is at the heart of many ... and politicalStanford is establishing a $100 mill... issues, President John Hennessy announced today. ...ng of additional faculty and support new graduate ... in yearly funding now spent on energy research., ...
... MADISON, WI, JANUARY 12, 2009 - With recent incr...ions into alternative energy sources, the increase...roduction is likely in the future. This may be esp...ously, in part because perennially high residue am... residue left on the soil surface is a source of i...
Other Biology News:Entrepreneurs wanted for NJIT workshops about how to launch a business 2Stanford launches $100 million initiative to tackle energy issues 2Stanford launches $100 million initiative to tackle energy issues 3Stanford launches $100 million initiative to tackle energy issues 4Stanford launches $100 million initiative to tackle energy issues 5Preventing soil erosion in continuous corn 2
RNaseZap Wipes Refill from Ambion
Streptozotocin from Calbiochem
...nal to HDAC4 - ChIP Grade HDAC4 is a member of th...onsists of 1084 amino acid residues. Its C-termina...main of yeast HDA1. HDAC4, unlike other deacetylas...a process involving active nuclear export. Associa...
Histology, Immunohistochemistry & Tissue Array Services from Dominion Pharmakine S.L.
Biology Products: